Karen Hosking
University of Cambridge(GB)Cambridge University Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Ovarian cancer diagnosis and treatment, Molecular Biology Techniques and Applications, Cancer-related molecular mechanisms research, RNA modifications and cancer
Most-Cited Works
- → Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study(2016)295 cited
- → Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer(2020)55 cited
- → Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer(2022)39 cited
- → Molecular landscape and functional characterization of centrosome amplification in ovarian cancer(2023)22 cited
- → Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models(2022)16 cited
- → Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer(2015)16 cited
- → Predicting resistance to chemotherapy using chromosomal instability signatures(2025)9 cited
- → Predicting response to cytotoxic chemotherapy(2023)2 cited